TGFB1 and neoplasm: We used TCR transgenic mice - one devoid of CD4 nTreg and the other with < 1% Foxp3 CD8s - whose tumor-infiltrating T cells and perhaps those in lymphoid organs of tumor-bearing mice would be engaged by cognate antigen, as well as being exposed to tumor-produced TGFβ.